Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain.
about
Bioresponsive matrices in drug deliveryProgress and perspectives on targeting nanoparticles for brain drug delivery.Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Mechanisms of microbubble-facilitated sonoporation for drug and gene delivery.Multifunctional nanoparticles for brain tumor imaging and therapy.Ultrasound enhanced drug delivery to the brain and central nervous system.Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapyNoninvasive and targeted gene delivery into the brain using microbubble-facilitated focused ultrasound.Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study.Dynamic inversion enables external magnets to concentrate ferromagnetic rods to a central targetRecent Advances on Inorganic Nanoparticle-Based Cancer Therapeutic AgentsEvolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.Nanoparticles for imaging and treating brain cancerEffects on P-Glycoprotein Expression after Blood-Brain Barrier Disruption Using Focused Ultrasound and Microbubbles.Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system.Ultrasound-enhanced drug delivery for cancerImproved thrombolytic effect with focused ultrasound and neuroprotective agent against acute carotid artery thrombosis in rat.Focused Ultrasound-Induced Blood-Brain Barrier Opening: Association with Mechanical Index and Cavitation Index Analyzed by Dynamic Contrast-Enhanced Magnetic-Resonance ImagingUltrasound/Magnetic Targeting with SPIO-DOX-Microbubble Complex for Image-Guided Drug Delivery in Brain Tumors.Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.Focused ultrasound-mediated drug delivery through the blood-brain barrier.In Vivo application and localization of transcranial focused ultrasound using dual-mode ultrasound arrays.Neuromodulation accompanying focused ultrasound-induced blood-brain barrier opening.Alzheimer disease in a mouse model: MR imaging-guided focused ultrasound targeted to the hippocampus opens the blood-brain barrier and improves pathologic abnormalities and behavior.Drug delivery across the blood-brain barrier using focused ultrasound.Ultrasound-targeted microbubble destruction for chemotherapeutic drug delivery to solid tumorsThe application of sparse arrays in high frequency transcranial focused ultrasound therapy: a simulation studyImage-guided drug delivery to the brain using nanotechnology.Short-time focused ultrasound hyperthermia enhances liposomal doxorubicin delivery and antitumor efficacy for brain metastasis of breast cancer.Contrast-enhanced ultrasound imaging for the detection of focused ultrasound-induced blood-brain barrier opening.Investigation of temporal vascular effects induced by focused ultrasound treatment with speckle-variance optical coherence tomography.Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncologyEnhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound.Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model.Focused ultrasound simultaneous irradiation/MRI imaging, and two-stage general kinetic model.Externally modulated theranostic nanoparticlesNoninvasive and targeted drug delivery to the brain using focused ultrasound.Combining microbubbles and ultrasound for drug delivery to brain tumors: current progress and overview.
P2860
Q24629097-2F237F13-0448-455E-8997-7C62B2DE6314Q26740580-905FAB6A-9EF1-4C27-A10C-A64C2A754448Q26778701-9FB8F142-845B-4E02-8726-F78E34558ADFQ26830028-36AD671C-5FDD-4C0A-9689-68E5370187ADQ26859479-07643781-B8A3-4917-9C06-FDC4946942B9Q26865418-3CF23C9C-8AF9-4489-BBA5-26F97C5EB915Q26991618-76A8C7C5-356F-4554-8107-C0A18516D32EQ27004205-32F9A6E1-BECC-4419-971C-5E2254B400E8Q27312535-B00CB832-0056-431C-B260-69FF70A2BFABQ27334453-EA923882-D080-4750-BCC3-EA9991947528Q27335239-41262FEB-6E54-40F2-A351-0BDAB4F7D535Q28079607-C2556FC3-6CD8-4405-87FE-77F6B56D34E2Q28082016-F89DAB3C-5382-483F-9968-9E299F3BC258Q28394053-2A497F37-943E-4CF9-9A2E-8E5FBC104773Q28468445-43EDC2A8-36C7-461A-81AB-F60F14C51866Q28539271-655E98BD-B71D-496E-99E3-43A53B701D5AQ29035807-8ADCFEDF-EE6F-4866-806E-6415399428F8Q30356179-73EE7432-D5A3-4947-BA6E-860C0AB06BBAQ30374237-1C2BB7AE-07F1-4A2E-8A4B-D1B207D05A35Q30378616-A832CFC1-085B-44EF-918C-331D87375CC6Q30385033-74C6BF18-A325-404A-AB93-24BCF11E1804Q30388067-F50A4A31-8405-43D4-A452-29550E25FB40Q30394357-0CAF35AE-BAD0-4EB1-97AE-4B8818E97817Q30395756-F40AEB9D-DB2A-4642-98E4-BE80D081DCF2Q30400282-3DE9B003-86E6-4203-803A-B19E2BBC94C1Q30402133-C03B643C-09E3-42D1-B499-135A191B52D5Q30414698-C154176D-8AD1-45D6-AED8-1C6D7535DEE6Q30422904-E82B0EB7-833B-4E9A-9630-8B7CC4FB5D0EQ30424279-D4AE3362-77A3-4021-A5B9-66FF3BCAFEE2Q30426990-1CC3C2A5-2649-4E80-ABCD-A1148A653159Q30429246-2D2256C1-1320-42E9-B625-39E78C6CBD76Q30432455-C555A0D2-FDDA-47A8-84D5-08D442CACB6EQ30434125-B87F2E25-70B2-418C-84CC-C647D3A0635AQ30434475-2DF7B146-7FC2-418F-A4C9-4953C5592137Q30434707-49CBCE46-9035-46E3-A5AD-BAB8E8C2DB8EQ30435074-EE020AA0-769F-442C-8CE2-193792FBBC09Q30436125-07361020-A345-46BB-A8FE-0F95BAF29E0DQ30438597-C8DE592D-2D29-40AD-8B64-F7EFF4CCADFEQ30439968-C376E253-A9BC-4654-94C7-C72441BCED08Q30442623-493D36E7-30CE-4928-8764-D1AABC70C6DF
P2860
Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Magnetic resonance monitoring ...... erapeutic agents to the brain.
@ast
Magnetic resonance monitoring ...... erapeutic agents to the brain.
@en
type
label
Magnetic resonance monitoring ...... erapeutic agents to the brain.
@ast
Magnetic resonance monitoring ...... erapeutic agents to the brain.
@en
prefLabel
Magnetic resonance monitoring ...... erapeutic agents to the brain.
@ast
Magnetic resonance monitoring ...... erapeutic agents to the brain.
@en
P2093
P2860
P921
P356
P1476
Magnetic resonance monitoring ...... erapeutic agents to the brain.
@en
P2093
Chiung-Yin Huang
Hung-Wei Yang
I-Chou Tseng
Jia-Shin Wu
Jiun-Jie Wang
Kuo-Chen Wei
Pin-Yuan Chen
Po-Chun Chu
Tzu-Chen Yen
P2860
P304
15205-15210
P356
10.1073/PNAS.1003388107
P407
P50
P577
2010-08-09T00:00:00Z